- Home
- BHRB vs AVXL Comparison
BHRB vs AVXL Comparison
Compare BHRB & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHRB
- AVXL
- Stock Information
- Founded
- BHRB 1852
- AVXL 2004
- Country
- BHRB United States
- AVXL United States
- Employees
- BHRB N/A
- AVXL N/A
- Industry
- BHRB Major Banks
- AVXL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BHRB Finance
- AVXL Health Care
- Exchange
- BHRB Nasdaq
- AVXL Nasdaq
- Market Cap
- BHRB 843.3M
- AVXL 794.0M
- IPO Year
- BHRB N/A
- AVXL N/A
- Fundamental
- Price
- BHRB $61.19
- AVXL $9.32
- Analyst Decision
- BHRB Strong Buy
- AVXL Strong Buy
- Analyst Count
- BHRB 2
- AVXL 2
- Target Price
- BHRB $73.00
- AVXL $44.00
- AVG Volume (30 Days)
- BHRB 66.5K
- AVXL 927.5K
- Earning Date
- BHRB 07-25-2025
- AVXL 08-05-2025
- Dividend Yield
- BHRB 3.62%
- AVXL N/A
- EPS Growth
- BHRB 46.75
- AVXL N/A
- EPS
- BHRB 3.98
- AVXL N/A
- Revenue
- BHRB $288,679,000.00
- AVXL N/A
- Revenue This Year
- BHRB $51.95
- AVXL N/A
- Revenue Next Year
- BHRB $4.56
- AVXL N/A
- P/E Ratio
- BHRB $15.28
- AVXL N/A
- Revenue Growth
- BHRB 168.50
- AVXL N/A
- 52 Week Low
- BHRB $47.28
- AVXL $4.00
- 52 Week High
- BHRB $75.32
- AVXL $14.44
- Technical
- Relative Strength Index (RSI)
- BHRB 66.89
- AVXL 60.62
- Support Level
- BHRB $57.65
- AVXL $9.09
- Resistance Level
- BHRB $59.45
- AVXL $9.78
- Average True Range (ATR)
- BHRB 1.64
- AVXL 0.41
- MACD
- BHRB 0.31
- AVXL 0.09
- Stochastic Oscillator
- BHRB 83.97
- AVXL 71.58
About BHRB Burke & Herbert Financial Services Corp.
Burke & Herbert Financial Services Corp is the bank holding company. Through its subsidiary, it predominantly serves small to medium-sized businesses, their owners and employees, professional corporations, non-profits, and individuals with various banking products and financial services. Some of its products and service offerings include checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential mortgage, acquisition, construction, and development loans, online banking, mobile banking, and wealth and trust services. The company operates in a single segment, namely Community Banking.
About AVXL Anavex Life Sciences Corp.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.